TGR5 has emerged as a promising therapeutic target for obesity and metabolic disorders due to its regulatory roles in energy expenditure, glucose homeostasis, thermogenesis, and gut hormone secretion. The gene discussed is GPBAR1; the disease is obesity due to melanocortin 4 receptor deficiency.